Elegir campos a generar del autor Cristina

Datos personales Todos / Ninguno
Correo Electrónico
Artículos Todos / Ninguno
Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1
Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study
Trends in phase III randomized controlled clinical trials on the treatment of advanced non‐small‐cell lung cancer
Seguridad de boceprevir y telaprevir en la práctica clínica habitual
A new fractioning process to decrease the price of ranibizumab
Métricas del autor Todos / Ninguno
Indice H